Publication #6983

Reference
MSAN(2020)63
Name
Phenelzine (Nardil) 15mg tablets
Categories
Scottish Government Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS SCOTLAND DRUGS SAFETY RISKS PHARMACEUTICAL INDUSTRY DRUG THERAPY PHARMACEUTICAL SERVICES SUPPLIES
Description
1. Phenelzine 15mg tablets (Nardil®) have been unavailable since August 2019 and this is now expected to be a long-term supply issue. There is currently no confirmed resupply date.
2. Phenelzine is an irreversible monoamine oxidase inhibitor (MAOI) licensed for the treatment of depression clinically characterised as 'atypical', 'non endogenous', 'neurotic' or which has not responded to treatment with other antidepressants.
3. It is clinically unsafe to stop or switch this drug abruptly, therefore, any switching or withdrawal will need to be undertaken by a specialist.
4. Unlicensed imports of phenelzine 15mg tablets were being used to manage patients and maintain treatment, however, due to global supply issues, these imports have become unreliable.
5. Supplies of unlicensed phenelzine 15mg capsule specials have become available.

Contact Name
Contact Email
Contact Address
Contact Phone

Created
2020-06-29 00:00:00


Click to go back to homepage